Navigation Links
Life Technologies Announces First Quarter 2013 Results
Date:5/2/2013

les, and Bioproduction.  Japan growth was primarily due to Ion Torrent and Bioproduction sales, offset by lower sales from government stimulus programs that took place in the same period last year.

OutlookThe Company anticipates revenue in the range of $950 million to $955 million and non-GAAP diluted earnings per share in the range of $0.94 to $0.97 for the quarter ending June 30, 2013, due to the impact from the fluctuations in currency rates, and the timing of operating expenses and larger deals compared to the guidance provided on February 4, 2013. Based on March 31, 2013 rates, currency is expected to have a negative impact of $62 million to revenue and a negative $0.15 impact to non-GAAP EPS for the full year.

Conference CallsGiven the recent announcement that Life Technologies and Thermo Fisher have entered into a definitive merger agreement under which Thermo Fisher will acquire all of the outstanding shares of Life Technologies for $76.00 per share in cash, the Company will no longer hold conference calls for its quarterly and annual earnings. The transaction, which is expected to close early in 2014, is subject to a Life shareholder vote and satisfying customary closing conditions, including regulatory approvals.

About Life Technologies Life Technologies Corporation (NASDAQ:  LIFE) is a global biotechnology company that is committed to providing the most innovative products and services to leading customers in the fields of scientific research, genetic analysis and applied sciences. With a presence in more than 180 countries, the company's portfolio of 50,000 end-to-end solutions are secured by more than 5,000 patents and licenses that span the entire biological spectrum -- scientific exploration, molecular diagnostics, 21st century forensics, regenerative medicine and agricultural research. Life Technologies has
'/>"/>

SOURCE Life Technologies Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. Palatin Technologies, Inc. to Report Fiscal Year 2012 First Quarter Results; Teleconference and Webcast to be held on November 15, 2011
2. UV Flu Technologies Expands Its International Footprint
3. Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on November 15, 2011
4. OrthoAccel® Technologies, Inc. Announces Definitive Distribution Agreement in Italy
5. Hologic to Showcase 3D Mammography (Breast Tomosynthesis) and Other Advanced Womens Imaging Technologies at RSNA 2011, the Largest Radiology Show in the World
6. Modern Mobility Aids, Inc. Secures Financing to Close Acquisition Agreement of LumiGene Technologies
7. Senesco Technologies, Inc. to Webcast, Live, at RetailInvestorConferences.com on December 1st
8. Animal Biotechnology - Technologies, Markets and Companies
9. Gene Therapy - Technologies, Markets and Companies
10. Biomarkers - Technologies, Markets and Companies
11. Palatin Technologies to Present at Windhovers Therapeutic Area Partnerships Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... , Jan. 14, 2014  3D Communications, a leading provider of ... regulatory, business, and media events in the United States ... former associate Virginia Cox , JD, is returning to the ... Virginia Cox re-joins 3D after more than two years of ...
(Date:1/14/2014)... January 14, 2014 EquitiesIQ, a leading ... (OTCQB: ALQA). Alliqua is an emerging biomedical company acquiring, ... wound care market. , Free report download: http://equitiesiq.com/reports/alliqua/ ... a seasoned management team and Board, which launched the ...
(Date:1/14/2014)... BETHESDA, Md. , Jan. 14, 2014  Organovo announced ... from the National Institutes of Health (NIH) to help ... effective treatments to patients on a faster timeline. Organovo ... Sciences (NCATS) and the National Eye Institute (NEI) to ...
(Date:1/14/2014)... In recent years, growing suspicion about the ... development and promotion has led to unprecedented levels of ... concerns about the insidious impact of commercialization of research, ... to the world’s biggest pharmas for illegal marketing activities, ...
Breaking Biology Technology:Former FDA Associate Commissioner Returns To 3D Communications 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3Organovo Announces Collaboration with National Institutes of Health 2Organovo Announces Collaboration with National Institutes of Health 3The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 3
... 18 Germany is on the,cutting edge in biotechnology ... production. Companies located in Germany are poised to,profit from ... an expert panel, at the BIO International Convention (BIO ... Germany co-chaired the,panel along with the CEO of a ...
... 18 Inverness Medical,Innovations, Inc. (Amex: IMA ... products for the consumer and professional markets, today,announced ... Russell, Vice,President, Finance, will attend the Jefferies 2nd ... York. Inverness, presentation is,scheduled for Wednesday, June 25 ...
... Synovics,Pharmaceuticals, Inc. (OTC Bulletin Board: SYVC), a ... subsidiary,Kirk Pharmaceuticals, LLC (Kirk) during the past year ... list of clients that includes Target,Walgreens, Family Dollar, ... these retailers are all over-the-counter (OTC) private label ...
Cached Biology Technology:BIO 2008: Germany on Cutting Edge in Biomanufacturing 2Inverness Medical Innovations to Present at Jefferies 2nd Annual Healthcare Conference held on June 25, 2008 2Synovics Pharmaceuticals Announces Continued Growth of Customer Relationships 2Synovics Pharmaceuticals Announces Continued Growth of Customer Relationships 3Synovics Pharmaceuticals Announces Continued Growth of Customer Relationships 4Synovics Pharmaceuticals Announces Continued Growth of Customer Relationships 5
(Date:7/10/2014)... National Cancer Research Centre (CNIO) Macromolecular Crystallography Group ... protein called BuD to DNA in order to ... the researcher who led the study, says the ... the instructions contained in the genome to treat ... study is published in the journal Acta ...
(Date:7/10/2014)... control everyday household items such as washing machines could ... a new study has claimed., As part of an ... mathematicians, including those from the University of Exeter, have ... be replicated in the natural world to help restock ... - in essence a built-in feedback control mechanism to ...
(Date:7/10/2014)... Scientists at The University of Manchester are a step closer ... patients that undergo gastric bypass surgery. , The research, published ... likely to be explained by the actions of specialised cells ... when we eat. , During the research, the ... just one hormone, had up to six hormones including the ...
Breaking Biology News(10 mins):CNIO scientists develop technology to redirect proteins towards specific areas of the genome 2Feedback control could be key to robust conservation management 2Scientists discover clues why weight-loss surgery cures diabetes 2
... a new type of 'bio-gel' which provides a pH neutral ... journal Advanced Materials (March 2006). , The gel is the ... of amino acids) to provide an environment in which cells ... mimics the properties of cell scaffolds which naturally occur in ...
... chemists have developed "self-exploding" microcapsules that could one day ... weeks or even months after injection. The study, by ... Louvain, is scheduled to appear in the Jan. 9, ... Biomacromolecules . , Unlike some other microcapsules, ...
... structures that are treated differently as a cell divides, UT ... could help lead to cancer therapies. , The study ... Cell ?focuses on the ends of DNA, which are capped ... telomeres shorten. When they become too short, the aging cell ...
Cached Biology News:Manchester scientists create new bio-gel for 3D cell culture 2DNA end caps may lead to cancer treatments, UT Southwestern researchers report 2
Adhesive seal-tab, for HybriWell™ hybridization sealing system *set of 400*...
... cell culture systems provide an integrated ... staining and imaging. Each system uses ... optical-quality coverslips in cell culture plates. ... and ready to use. Individual chambered ...
RECOMBINANT EQUINE IL-4 Product Type: Recombinant Protein...
RECOMBINANT EQUINE TNF ALPHA Product Type: Recombinant Protein...
Biology Products: